Creative Biolabs to Host Webinar on Tumoroid-on-a-Chip Technology

Creative Biolabs has announced an upcoming webinar scheduled for August 22, 2025, focusing on the innovative tumoroid-on-a-chip platform. This microfluidic-based 3D tumor model is designed to significantly enhance the accuracy of preclinical testing, offering a more physiologically relevant environment for drug testing. The webinar will be presented by Dr. Mohsen Akbari, an Associate Professor at the University of Victoria and the Director of the Laboratory for Innovations in Microengineering (LiME). Dr. Akbari's presentation aims to explore how this cutting-edge technology is transforming the landscape of cancer research.

The tumoroid-on-a-chip technology marks a substantial advancement over traditional 2D cultures by accurately mimicking the structural and cellular complexity of solid tumors. This breakthrough is particularly vital for early-stage drug development and immunotherapy screening, as it enables a more precise evaluation of drug responses. Such precision could effectively narrow the gap between laboratory findings and their clinical applications, paving the way for more effective cancer treatments.

Key discussion points of the webinar will include the development of tumor chips, methods for integrating cellular heterogeneity and extracellular matrix (ECM) complexity, and the utilization of these systems in preclinical drug testing and personalized oncology. With his profound expertise in microengineering and biomaterials, along with a notable publication record, Dr. Akbari is uniquely positioned to lead the conversation on the future of tumor modeling technologies.

Creative Biolabs is at the forefront of oncology research, offering a wide range of 3D tumor modeling platforms. These include Ex Vivo Tissue Models, Precision-Cut Tissue Slicing Models, 3D Spheroid Models, 3D Organoid Models, and Organ-on-a-Chip Models. These platforms play a critical role in assessing drug responses under conditions that closely replicate the in vivo tumor microenvironment, especially in the realms of immuno-oncology and combination therapy studies. For more information on their research and technologies, visit https://www.creative-biolabs.com.